Senescent human astrocytes impair neuronal mitochondrial function through released factors
Conditioned medium from damaged astrocytes alters extracellular mitochondria and triggers ATP depletion and oxidative stress in human postmitotic neurons.
Antioxidants (Basel, Switzerland) · Amorim P et al. · Paper published 6 Sep 2026
In cultured primary human astrocytes and human postmitotic neurons, researchers investigated how astrocyte senescence influences neuronal mitochondrial health. The team induced senescence in human astrocytes using doxorubicin. These senescent astrocytes accumulated smaller, ultrastructurally damaged mitochondria alongside elevated fission, fusion, and biogenesis markers. Despite this expansion, the senescent astrocytes exhibited lower mitochondrial membrane potential, reduced ATP, and decreased cellular metabolic activity. Senescence also altered the extracellular space. Conditioned medium from senescent astrocytes carried fewer mitochondrial particles with lower membrane potential and less ATP. When exposed to this medium, human postmitotic neurons experienced hydrogen peroxide accumulation, ATP depletion, and reduced metabolic activity without overt cell death. In contrast, medium from control astrocytes boosted neuronal levels of TOMM20 and PGC-1alpha.
Why it matters
Astrocyte senescence is a recognized feature of brain aging. These findings demonstrate that senescent astrocytes directly compromise neuronal energy metabolism and redox balance by remodeling extracellular mitochondrial support.
Caveats
The study was conducted exclusively in cell culture using drug-induced senescence, which may not fully reflect the chronic, complex mechanisms of astrocyte aging in living human brain tissue.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Astrocyte Senescence Disrupts the Extracellular Mitochondrial Compartment and Compromises Bioenergetic Support to Human Neurons
Amorim P, Hayashide LS, Leocadio VE et al.
Antioxidants (Basel, Switzerland) · 6 Sep 2026 · Peer-reviewed
- Relevance
- Core geroscience
- News value
- Notable
- Evidence
- Cells
- Status
- Peer-reviewed
More on Mitochondria
See allCardiolipin loss drives muscle fiber shifts during aging via a nuclear receptor
Restoring cardiolipin synthesis in knockout mice reversed muscle atrophy and prevented premature death.
Nature aging · Finger F et al.
Early-life mitochondrial DNA mutations drive age-related pathology in mice
Manipulating mitochondrial fusion can alter tissue-specific selection against deleterious variants that arise early in development.
bioRxiv · Shemtov SJ et al.
Inhibiting miR-128-3p restores muscle mass and function in aged mice
The microRNA inhibitor also improved cardiac outcomes after infarction and reduced pathology in mouse and pig models of muscular dystrophy.
bioRxiv : the preprint server for biology · Boldridge MA et al.
Prodh2 inhibition alleviates muscle atrophy and restores strength in COPD mice
TNF-alpha triggers a mitochondrial immune pathway via Prodh2 that damages myoblasts, while silencing the enzyme restores muscle strength in mice.
Aging cell · Chen G et al.
Depp1 drives muscle loss under fasting and low oxygen in mice
The study reveals that the protein localizes to mitochondria to regulate autophagy and mitochondrial degradation during nutrient and oxygen limitation.
bioRxiv · Qayyum S et al.